CRSP vs EDIT
CRSP 与 EDIT 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | CRSPCRISPR THERAPEUTICS AG | EDITEDITAS MEDICINE, INC. |
|---|---|---|
| 市值 | $4.85B | $402.38M |
| 市销率 | 1397.0x | 9.9x |
| 营收同比增长 | -90.6% | 25.4% |
| 净利同比增长 | -58.8% | 32.5% |
| 息税前利润率 | -18933.6% | -394.9% |
| 净资产收益率 | -35.3% | -152.0% |
| 投入资本回报率 | -32.5% | — |
| 一年总回报 | -18.5% | -14.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:CRSP vs EDIT
| 指标 | CRSP | EDIT |
|---|---|---|
| 期末价值 | $35.5K | $1.9K |
| 总回报 | +254.8% | -81.3% |
| 年化收益 (CAGR) | +13.4% | -15.4% |
| 波动率 | 63.9% | 84.3% |
| 夏普比率 | 0.45 | 0.16 |
| 索提诺比率 | 0.69 | 0.24 |
| 最大回撤 | -85.1% | -98.9% |
基于 2524 个共同交易日,2016-10-19 → 2026-11-03 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)